DOMME Dose Optimization Multicentric Mexican Evaluation
clinical trial
Press Enter · cited answer in seconds
0 sources
DOMME Dose Optimization Multicentric Mexican Evaluation
Summary
DOMME Dose Optimization Multicentric Mexican Evaluation is a clinical trial[1].
Key Facts
- DOMME Dose Optimization Multicentric Mexican Evaluation is in the country of Mexico[2].
- DOMME Dose Optimization Multicentric Mexican Evaluation's instance of is recorded as clinical trial[3].
- DOMME Dose Optimization Multicentric Mexican Evaluation's start time is recorded as +2007-04-30T00:00:00Z[4].
- DOMME Dose Optimization Multicentric Mexican Evaluation's end time is recorded as +2008-12-31T00:00:00Z[5].
- DOMME Dose Optimization Multicentric Mexican Evaluation's sponsor is recorded as Sanofi[6].
- DOMME Dose Optimization Multicentric Mexican Evaluation's main subject is recorded as diabetes[7].
- DOMME Dose Optimization Multicentric Mexican Evaluation's number of participants is recorded as {'unit': '1', 'amount': '+371'}[8].
- DOMME Dose Optimization Multicentric Mexican Evaluation's title is recorded as Multicentric, Open Label Clinical Trial. Use of Optimal Method to Initiate and Maintain Lantus Therapy (Insulin Glargine) in Combination With Hypoglycemic Agents, Assessing the Resulting Metabolic Control and the Safety in T2 Diabetes Mellitus Patients.[9].
- DOMME Dose Optimization Multicentric Mexican Evaluation's short name is recorded as DOMME[10].
- DOMME Dose Optimization Multicentric Mexican Evaluation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- DOMME Dose Optimization Multicentric Mexican Evaluation's ClinicalTrials.gov ID is recorded as NCT00488527[12].
- DOMME Dose Optimization Multicentric Mexican Evaluation's research intervention is recorded as insulin glargine[13].
- DOMME Dose Optimization Multicentric Mexican Evaluation's clinical trial phase is recorded as phase IV clinical trial[14].
- DOMME Dose Optimization Multicentric Mexican Evaluation's research site is recorded as Sanofi[15].
- DOMME Dose Optimization Multicentric Mexican Evaluation's research subject recruitment status is recorded as completed[16].
- DOMME Dose Optimization Multicentric Mexican Evaluation's study type is recorded as interventional study[17].